Nevirapine (Breckenridge Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Nevirapine drug offered from Breckenridge Pharmaceutical, Inc.. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | NEVIRAPINE |
SUBSTANCE NAME: | NEVIRAPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-04-11 |
END MARKETING DATE: | 0000-00-00 |
Nevirapine HUMAN PRESCRIPTION DRUG Details:
Item Description | Nevirapine from Breckenridge Pharmaceutical, Inc. |
LABELER NAME: | Breckenridge Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2011-04-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51991-331_996b0adc-01de-4c25-995e-ba95ce8059d4 |
PRODUCT NDC: | 51991-331 |
APPLICATION NUMBER: | ANDA078644 |
Other NEVIRAPINE Pharmaceutical Manufacturers / Labelers: